Providing Postmarket Periodic Safety Reports in the ICH E2C(R2) Format (Periodic Benefit-Risk Evaluation Report)
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
November 29, 2016
December 19, 2024
39cb6b72-e49f-4e02-ba0b-172f4a5701a2
Related Documents
Providing Submissions in Electronic Format — Postmarketing Safety Reports
Guidance DocumentApril 27, 2022Center for Drug Evaluation and Research
Pre-Launch Activities Importation Requests (PLAIR): Guidance for Industry
Guidance DocumentMarch 1, 2022Center for Drug Evaluation and Research
Tropical Disease Priority Review Vouchers
Guidance DocumentOctober 6, 2016Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.